# Immune Metabolism Dysregulation and Efficacy to Anti-PD-1 PD-L1 Agents in Non Small Cell Lung Cancer Patients

> **NCT07637474** · — · RECRUITING · sponsor: **Regina Elena Cancer Institute** · enrollment: 150 (estimated)

## Conditions studied

- Nsclc

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07637474
- **Lead sponsor:** Regina Elena Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-24
- **Primary completion:** 2026-07-24
- **Final completion:** 2026-07-24
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-06-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07637474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07637474, "Immune Metabolism Dysregulation and Efficacy to Anti-PD-1 PD-L1 Agents in Non Small Cell Lung Cancer Patients". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07637474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*